We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

2 hedge funds and large institutions have $42.1K invested in Global Blood Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 239 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 247 → 2 (-245)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $4.73B → $42.1K (-$4.73B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 239

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-245
Holders Change %
-99.19%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
239
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$428M
2
BlackRock
BlackRock
New York
-$323M
3
BBA
Baker Bros. Advisors
New York
-$254M
4
PCM
Pentwater Capital Management
Florida
-$218M
5
State Street
State Street
Massachusetts
-$162M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
151
AQR Capital Management
Connecticut
– -$1.27M -18,720 Closed
BCM
152
BCK Capital Management
Connecticut
– -$1.23M -18,098 Closed
FC
153
FORA Capital
Florida
– -$1.19M -17,528 Closed
FIA
154
FNY Investment Advisers
New York
– -$1.18M -17,300 Closed
Principal Financial Group
155
Principal Financial Group
Iowa
– -$1.15M -16,835 Closed
ASRS
156
Arizona State Retirement System
Arizona
– -$1.14M -16,806 Closed
JMPWA
157
JP Morgan Private Wealth Advisors
California
– -$1.05M -15,431 Closed
LOAMU
158
Lombard Odier Asset Management (USA)
New York
– -$1.02M -15,000 Closed
Skandinaviska Enskilda Banken (SEB)
159
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$1.02M -15,000 Closed
EPM
160
Equitec Proprietary Markets
Illinois
– -$940K -13,800 Closed
TRCT
161
Tower Research Capital (TRC)
New York
– -$938K -13,771 Closed
ProShare Advisors
162
ProShare Advisors
Maryland
– -$872K -12,797 Closed
Handelsbanken Fonder
163
Handelsbanken Fonder
Sweden
– -$861K -12,644 Closed
SO
164
STRS Ohio
Ohio
– -$810K -11,900 Closed
VEA
165
Virtus ETF Advisers
New York
– -$719K -10,558 Closed
AB
166
Amalgamated Bank
New York
– -$712K -10,450 Closed
QT
167
Quantbot Technologies
New York
– -$701K -10,300 Closed
Zurich Cantonal Bank
168
Zurich Cantonal Bank
Switzerland
– -$701K -10,291 Closed
Vontobel Holding
169
Vontobel Holding
Switzerland
– -$681K -10,000 Closed
DCM
170
Dupont Capital Management
Delaware
– -$652K -9,567 Closed
Public Employees Retirement Association of Colorado
171
Public Employees Retirement Association of Colorado
Colorado
– -$634K -9,312 Closed
Los Angeles Capital Management
172
Los Angeles Capital Management
California
– -$602K -8,846 Closed
SG Americas Securities
173
SG Americas Securities
New York
– -$591K -8,674 Closed
YIH
174
Y-Intercept (HK)
Hong Kong
– -$566K -8,308 Closed
BW
175
Bison Wealth
Georgia
– -$553K -8,128 Closed
5 6
7
8 9

GBT Hedge Fund Activity: Q4 2022 in Review

2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q4 2022, worth a combined $42.1K — down 100% from $4.73B a quarter earlier.

Sellers outnumbered buyers: 239 funds closed out of GBT and 0 opened new positions — a net loss of 239 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $428M sold.

  • 2 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q4 2022, down from 247 in Q3 2022.
  • Funds reported $42.1K of Global Blood Therapeutics, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Global Blood Therapeutics, Inc. positions in Q4 2022 and 239 closed out, a net change of -239 holders.
  • The largest Global Blood Therapeutics, Inc. seller in Q4 2022 was Vanguard Group, an estimated $428M sold.

Based on aggregated 13F filings for Q4 2022.